#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ornithine transcarbamoylase deficiency Cardiac sarcoidosis Osteomyelitis Methylmalonic acidaemia Pyruvate kinase deficiency anaemia Philadelphia chromosome positive Paroxysmal nocturnal haemoglobinuria Pulmonary alveolar haemorrhage Urea cycle disorder Porphyria non-acute Raynaud's phenomenon HER2 mutant non-small cell lung cancer Hepatitis B Peritoneal neoplasm Diffuse large B-cell lymphoma refractory More trials…

    Learn about Rare Diseases

    Breast angiosarcoma Cytokine release syndrome – Trials in Disease Rhabdomyosarcoma recurrent – Life with Disease Primary immunodeficiency syndrome – Treatment Leukoencephalopathy – Life with Disease Rhabdoid tumour – Treatment Haemophagocytic lymphohistiocytosis – Basic Information Mast cell activation syndrome – Trials in Disease Lymphangioma – Basic Information Haemophilia A without inhibitors – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AB521 Atidarsagene Autotemcel Belatacept Pioglitazone Nemolizumab Gs-5245 Enzalutamide Umeclidinium Antipsychotics Oteracil Nelivaptan Zinc Sulphate Heptahydrate Masupirdine Minocycline Fexofenadine Hydrochloride Degarelix E.coli Polysaccharide Gadoteric Acid Mps-103 Nelarabine More therapies…

    Learn about Your Condition

    Extraskeletal ossification Breast neoplasm Burkitt's lymphoma Microvillous inclusion disease Dyskinesia Diabetic retinal oedema T-cell lymphoma Facial paresis Small fibre neuropathy Dedifferentiated liposarcoma Glaucoma Muscle strain Meningioma Influenza Medication overuse headache More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Satasairaala

Satasairaala

Sairaalantie 3, Pori, 28500, Finland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Apixaban and Edoxaban for Preventing Stroke in Patients with Recent Perioperative Atrial Fibrillation After Noncardiac Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    • Cerebrovascular accident
    • Haemorrhage
    Investigated Drugs:
    • Dabigatran
    • Edoxaban
    • Apixaban
    Belgium Denmark Finland France Germany Greece +5

  • Study on Apixaban for Preventing Stroke in Patients with Atrial Fibrillation and Stage 5 Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    • Chronic kidney disease
    • End stage renal disease
    Investigated Drugs:
    • Apixaban
    Finland France Iceland The Netherlands Norway Poland +1

  • Diagnostic PET Study of Al[18F]F-NOTA-folate in Patients with Suspected Cardiac Sarcoidosis or Infective Endocarditis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Endocarditis bacterial
    Finland

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!